Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,683 public trials 1,032 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Recruiting

Observational Multicenter Study in Patients Receiving Chemotherapy and Amivantamab for Metastatic Non-small Cell Lung Cancer

NCT07563205

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +16 more
Locations
  • CH du Pays d Aix - Service des Maladies Respiratoires Aix-en-Provence, France
  • APHP Hôpital Avicennes Bobigny, France
  • Hôpital Louis Pradel Bron, France
  • Pneumologie Centre François Baclesse Caen, France
View all 16 locations
View Trial Details
Recruiting

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients

NCT05899608

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Banner University Medical Center Phoenix, Arizona, United States
  • TMC Healthcare Tucson, Arizona, United States
  • Genesis Cancer and Blood Institute Hot Springs, Arkansas, United States
  • University of Arkansas Little Rock, Arkansas, United States
View all 253 locations
View Trial Details
Recruiting

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

NCT05297734

Conditions
Adenocarcinoma, Adnexal Diseases, Astrocytoma, +81 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of South Alabama Mobile, Alabama, United States
  • Beckman Research Institute of City of Hope Duarte, California, United States
  • VA Medical Center, Fresno Fresno, California, United States
View all 17 locations
View Trial Details
Recruiting

Clinical Trial of AMG510 in Stage III Unresectable NSCLC KRAS p.G12C Patients and Ineligible for Chemo-radiotherapy

NCT05398094

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Hospital General Universitario de Alicante Alicante, Spain
  • ICO Badalona, Hospital Germans Trias i Pujol Badalona, Barcelona, Spain
  • Hospital Universitari Quiron Dexeus Barcelona, Spain
  • Hospital Universitari Vall d' Hebron Barcelona, Spain
View all 20 locations
View Trial Details
Recruiting

TRIMPACT: Real-World First-Line Atezolizumab Use in Stage IV NSCLC With PD-L1 ≥50%

NCT07279402

Conditions
Atezolizumab, Bronchial Neoplasms, Carcinoma, Bronchogenic, +11 more
Locations
  • Adana City Hospital Adana, Turkey (Türkiye)
  • Afyonkarahisar Health Sciences University Hospital Afyonkarahisar, Turkey (Türkiye)
  • Ankara Oncology Training and Research Hospital Ankara, Turkey (Türkiye)
  • Memorial Ankara Hospital Ankara, Turkey (Türkiye)
View all 25 locations
View Trial Details
Recruiting

Mechanisms of Resistance to Amivantamab in Patients With NSCLC With EGFR Exon 20 Insertion

NCT06247826

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Oncologie Polyclinique Bordeaux Nord Aquitaine Bordeaux, France
  • Centre Hospitalier du Morvan Brest, France
  • Pneumologie Centre Hospitalier Intercommunal de Créteil Créteil, France
  • Oncologie, CLCC Dijon Dijon, France
View all 18 locations
View Trial Details
Recruiting

Analysis of Biological Characteristics of Advanced ALK-rearranged NSCLC

NCT05122806

Conditions
ALK Gene Rearrangement Positive, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations
  • Pneumologie CHU Félix Guyon Saint-Denis, La Réunion, France
  • Centre Hospitalier d'Aix en Provence Aix-en-Provence, France
  • Pneumologie CHU Amiens, France
  • Centre Hospitalier Universitaire Angers, France
View all 46 locations
View Trial Details

Related conditions